• A unique collection of 3372 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS)
•Drug repurposing, the application of known drugs to treat new disease indication, holds potential of rapid clinical impact at a lower cost than de novo drug development
• Safety confirmed by clinical phase 1
• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc
• Structurally diverse, medicinally active, and cell permeable.
• Rich documentation with structure, IC50, and customer reviews
• NMR and HPLC validated to ensure the highest purity
Product Details
Formulation
2991 compounds pre-dissolved in 10mM DMSO, 274 compounds pre-dissolved in 10mM water, 88 compounds pre-dissolved in 2mM DMSO and 19 compounds pre-dissolved in 2mM water
Container
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Stability
12 months-20°Cin DMSO
24 months-80°Cin DMSO
FDA-approved & Passed Phase I Drug Library Composition